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Abstract
Breast cancer stem cells (CSCs) are thought to drive recurrence and metastasis. Their iden-
tity has been linked to the epithelial to mesenchymal transition (EMT) but remains highly
controversial since—depending on the cell-line studied—either epithelial (E) or mesenchy-
mal (M) markers, alone or together have been associated with stemness. Using distinct
transcript expression signatures characterizing the three different E, M and hybrid E/M cell-
types, our data support a novel model that links a mixed EM signature with stemness in 1)
individual cells, 2) luminal and basal cell lines, 3) in vivo xenograft mouse models, and 4) in
all breast cancer subtypes. In particular, we found that co-expression of E and M signatures
was associated with poorest outcome in luminal and basal breast cancer patients as well as
with enrichment for stem-like cells in both E and M breast cell-lines. This link between a
mixed EM expression signature and stemness was explained by two findings: first, mixed
cultures of E and M cells showed increased cooperation in mammosphere formation (indic-
ative of stemness) compared to the more differentiated E and M cell-types. Second, single-
cell qPCR analysis revealed that E and M genes could be co-expressed in the same cell.
These hybrid E/M cells were generated by both E or M cells and had a combination of sever-
al stem-like traits since they displayed increased plasticity, self-renewal, mammosphere
formation, and produced ALDH1+ progenies, while more differentiated M cells showed less
plasticity and E cells showed less self-renewal. Thus, the hybrid E/M state reflecting stem-
ness and its promotion by E-M cooperation offers a dual biological rationale for the robust
association of the mixed EM signature with poor prognosis, independent of cellular origin.
Together, our model explains previous paradoxical findings that breast CSCs appear to be
M in luminal cell-lines but E in basal breast cancer cell-lines. Our results suggest that target-
ing E/M heterogeneity by eliminating hybrid E/M cells and cooperation between E and M
cell-types could improve breast cancer patient survival independent of breast cancer-
subtype.
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Introduction
Poor cancer patient survival has been linked to enrichment for cancer stem cells (CSCs) [1]
that are capable of undergoing the “metastatic cascade”, including invasion, migration, survival
in suspension, colonization and establishment of secondary tumors [2]. Thus, identification of
single CSCs by yet unknown markers promises to enable prediction of patient outcome, as well
as to facilitate targeting of therapy to these cells to improve patient survival. CSCs (or alterna-
tively ‘tumor-initiating cells‘), like normal stem cells, are thought to be capable of self-renewal
and plasticity, leading to heterogeneous progeny [3]. Due to their plasticity, normal mammary
epithelial stem cells give rise to both luminal and basal (myoepithelial) lineages [4]. Evidence is
accumulating that all breast cancer cells are derived from a common luminal stem-like cell
population that gives rise to both luminal and basal tumors [5–8]. A tight link between luminal
estrogen receptor (ER)+ and basal ER- breast tumors is also suggested by the observation that
antihormonal treatment of ER+ breast cancer patients with tamoxifen treatment increases risk
of contralateral development of ER- tumors [9]. While many prognostic signatures have been
identified, all of them predict poor patient outcome either in luminal ER+ or in basal ER- tu-
mors [10], thus requiring the context (microenvironment) of the particular tumor type to be
predictive, they are agnostic of the existence of a common CSC population for luminal and
basal breast cancer patients.
‘Stemness’ of tumor cells is measured in vitro by their ability to form mammospheres [11]
and in vivo by their tumor-initiation capability in immune-compromised mice. Mammosphere
formation, tumor initiation, as well as the early steps of the metastatic process that require sur-
vival of the disseminating cells as circulating tumor cells (CTCs) can be induced by an epitheli-
al-to-mesenchymal transition (EMT), which affords epithelial (E) tumor cells a mesenchymal
(M) phenotype [12–15]. Therefore, M cells are often considered CSCs, and E cells are consid-
ered ‘non-CSCs’ [16]. However, this simple dualism remains controversial for several reasons:
first, tumor initiation at metastatic sites requires epithelial gene expression, implying a mesen-
chymal-to-epithelial transition (MET) during later steps of the metastatic cascade facilitates
colonization [17]. Second, recent findings show that expression in primary tumors of epithelial
markers [18–20] but not mesenchymal markers [19,21,22] predict metastasis and poor out-
come in breast cancer patients. Third, in many cell-lines, CSC-related properties, such as mi-
gration or formation of mammospheres and increased tumorigenicity are often not associated
with expression of mesenchymal genes but rather with enrichment for epithelial gene expres-
sion in breast cancer [20,23,24] as well as in other carcinoma [23,25–27]. Therefore, CSC prop-
erties are not necessarily associated with the M phenotype but sometimes also with cells that
have the opposite, more E-like phenotype and express more E-specific genes. In brief, studies
in breast cancer patients, in cancer cell-lines in vitro and in xenograft animal models suggest
that the CSC characteristic is not a property that is intrinsically associated with the mesenchy-
mal state but must also bear some relationship with the epithelial state.
We noticed that in many cancerous breast cell-lines with the luminal (epithelial) pheno-
types, such as HMLE, HMLER, and MCF7 cells [12–14], the CSC-enriched population was
consistently associated with high expression of M genes, whereas in cell-lines with basal (mes-
enchymal) morphology, such as BT-549, MDA-MB231, or 4T07, the CSC-enriched population
expressed more E genes [20,23,24]. This suggests that the context for E molecular marker sig-
natures to indicate stemness may be the M tumor cell-lines, whereas conversely, the M marker
signatures indicate stemness when expressed in E tumor cell-lines. Given the plasticity of both
normal stem cells and cancer stem-like cells that can give rise to both luminal and basal line-
ages it is possible that a common signature can identify the CSC-enriched populations in breast
cancer cells and in patients—independent of the cell line or tumor-context being epithelial,
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mesenchymal, luminal, or basal. This signature could appear epithelial relative to the mesen-
chymal bulk tumor cells, but mesenchymal in the context of mostly epithelial tumor cells.
Therefore we hypothesized that stemness is associated with cells exhibiting a hybrid E/M
state, cells simultaneously expressing both E and Mmarkers. This hybrid state is possibly the
result of an ‘incomplete EMT’ for E cells and an ‘incomplete MET’ for M cells as suggested pre-
viously [5,28,29]. In stem cell biology the concept of promiscuous gene expression patterns in
bi-potential progenitor cells has long been proposed on theoretical grounds and demonstrated
in in vitromodels that display a promiscuous phenotype between the prospective lineages fates
[30,31]. Indeed, in xenograft animal studies, it has been observed that small populations of
CSCs for example isolated from breast [32–34] and ovarian cancer [35] co-expressed different
E (EPCAM, CD24, or ALDH) and M (CD44) cell surface markers.
However, several questions remain open: (1) the “extreme” (pure) E and M states as well as
the intermediate E/M state have not been explicitly described yet by the expression of definite
sets of genes which have been very inconsistent between different tumor cell lines. (2) With re-
gard to the metastatic potential and poor survival in ER+ and ER- breast cancer patients there
is still no evidence for the functional relevance of hybrid E/M state. (3) In whole-tissue gene ex-
pression profiles that are routinely measured, the ‘co-expression’ of E and Mmarkers may be
the consequence of a mixture of relatively differentiated E and M cells as opposed to the pres-
ence of individual stem-like cells in the postulated hybrid E/M state.
Results
Identification of luminal epithelial and basal mesenchymal genes in
HMLER cells
To discriminate the hybrid E/M state from the more extreme E and M cell states, we first deter-
mined the genes most specifically expressed in morphologically E and M cell-types (Fig 1A).
To this end we used the well characterized tumorigenic HMLER cells because they contain
both epithelial CD24+/CD44- (also previously designated CD24+/CD44lo) and mesenchymal
CD24-/CD44+ (CD24-/CD44hi) cell-types that can interconvert into each other [13,36], are
genetically mostly identical and thus comparable with each other. HMLER cells are derived
from normal human mammary epithelial (HMEC) cells by consecutive immortalization and
transformation with hTERT and the SV40LT and RAS oncogenes [37]. By single cell-sorting
we generated morphologically stable (> 20 passages) CD24+/CD44-(E) clones and CD24-/
CD44+(M) clones (S1 Fig); E clones had the typical epithelial cobble stone-like morphology
with tight cell-cell contacts, while M clones grew rather as dispersed cells and had fibroblast-
like morphology (Fig 1A). To derive the most differentially expressed genes between these op-
posite E and M phenotypes, we compared transcriptomes of six E and four M clones with each
other. E and M-specific genes were ranked by their differential expression in the E clones versus
M clones (designated E_HMLER and M_HMLER gene sets, S1 and S2 Tables, Fig 1B).
Previously, independent E and M gene sets have been reported by differential overexpres-
sion of genes in the parental HMLE cells that promote the E versusM type cells. Cells were ren-
dered M by overexpression of either TWIST, SNAIL, siCDH1, GSC or TGFβ treatment, and
highly expressed genes (M genes) were designated as ‘EMT core signature’ [22]. HMLE cells
are less tumorigenic and not transformed with the RAS oncogene as HMLER cells. HMLE E
and M gene sets substantially overlapped with the E_HMLER and M_HMLER signatures but
also contained unique genes (Fig 1B, S2 Table, S1 Fig). Similarly, lung-specific E and M signa-
tures [38] (S2 Table) overlapped significantly with HMLER- and HMLE-derived E and M sig-
natures (Fig 1B), indicating that the E and M states defined by these genes are not specific for
RAS expression nor only breast-specific but associated with the respective opposite cellular
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Fig 1. In mammospheres E and M cell lines converge to an intermediate E/M gene expression state. (A) Phase-contrast (20x) images showing a
typical HMLERCD24+/CD44-(E) clone and a typical HMLERCD24-/CD44+(M) clone. Orange color refers to epithelial cells, and blue color to mesenchymal
cells throughout manuscript. (B) Heat map of the E and M-specific gene expression defined as the 150 most extreme differentially expressed genes between
morphological E clones and M clones (E_HMLER (150), and M_HMLER (150), S1 Table) in different HMLER cell-lines. RNA for gene expression arrays
shown was isolated from different cell line passages. Gene expression data were relative-normalized towards the intermediate expression between E and M
clones. Overlap with other E and M gene sets from different cell-types (HMLE cells and lung cancer) is shown on the right. (C) Phase-contrast (20x) images
showing mammospheres grown in suspension of epithelial HP cells and the mesenchymal M4 clone. (D) Heat map of E and M-specific genes expressed in
HP(E) and M4(M) cells when grown under adhesion and suspension mammospheres conditions. Normalization of gene expression was as in B, biological
duplicate arrays are shown. (E) GSEA of gene expression dynamics between cells grown in adhesion versus suspension from (D), assessed for the E- and
M-specific genes. (Normalized) Enrichment Scores (NES and ES) were based on duplicate arrays, had a false discovery rate q-value of < 0.0001 and a
family wise p-value < 0.01 (S3 Table).(F) Pearson correlation coefficient between whole transcriptomes from (D) for global profiles. Numbers in heatmap
represent the correlation average.
doi:10.1371/journal.pone.0126522.g001
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morphologies. As expected, among the most extremely expressed E_HMLER genes were well-
known E genes such as CDH1 (E-Cadherin), EPCAM (ESA), and CD24. The set of M_HMLER
genes contained connective tissue-specific genes such as VIM (Vimentin), DCN (Decorin) and
genes encoding several collagens and were characteristic for the mesenchymal-like ‘basal B’
cell-lines (S1 and S2 Tables). With respect to cell-lines derived from primary breast tumors, ac-
cording to the online GOBO tool [39] based on classification by Neve [40], E_HMLER and
M_HMLER genes correlated either with the luminal (epithelial) or basal B (mesenchymal) pa-
tient-derived cancer cell-lines, respectively (S1B Fig). This suggested that – relative to each
other – the HMLER-derived E and M gene sets indeed represent the typical cellular program
found in the more luminal-like and basal-like breast cancer cell-lines, respectively.
Mammospheres from E and M cell lines converge to an intermediate
E/M gene expression state
Mammospheres are not only derived from stem-like cells [11], but also enriched for cells with
stem-cell properties, such as tumorigenicity [41,42]. Thus, transcriptomes of mammospheres
may also show enrichment for genes characteristic of CSCs. Therefore, we analyzed the tran-
scriptomes of E and M HMLER cell populations grown in adhesion and as mammospheres in
suspension (Fig 1C). As representative for HMLER E populations we used the epithelial paren-
tal HMLER cells (here: HP cells, mostly CD24+/CD44- cells,<30% CD24-/CD44+ cells), since
in adhesion HP cells showed E-clone like transcriptomes with respect to E and M genes (Fig
1B). (E clone E5 mammospheres did not yield sufficient RNA for transcriptome analyses).
Conversely, as representative HMLER M population we used the M4 clone. We observed that
the majority of genes whose expression increased following the transition from adhesion to
mammosphere suspension cultures differed in the E and M cells, and thus depended on the
cell-type. However, about 15% of transcripts changed in a context-independent manner, i.e.,
were altered in both cell-lines (S2A Fig). Consistent with the reported enrichment for stem-like
cells, mammospheres from both, the HP and M4 cells displayed increased expression levels of
transcripts for the pluripotency factor OCT4 (POU5F1) relative to adherent cells (S2B Fig).
Also, both the HP and M4-derived mammospheres showed an increase of APOE and loss of
NRG1 expression as previously observed in mammospheres derived from normal breast
HMEC cells [11]. This suggested that, as in normal breast cells, both E and MHMLER cell pop-
ulations adopt a stem-like phenotype when grown as mammospheres.
In striking contrast to these cell-type-independent markers of stemness, the E- and M-spe-
cific genes changed in exactly opposing directions depending on the cell-type context, E (HP)
vs M (M4) cells (Fig 1D and S2A Fig). Specifically, epithelial HP cells exhibited a significant in-
crease of M-specific transcripts and some loss of E-specific transcripts as confirmed by gene set
enrichment analysis (GSEA) (Fig 1D and 1E) for signatures from both HMLER and HMLE
cells (S3 Table). This observation is consistent with the conventional notion of a link between
stemness of the cells in mammospheres and the mesenchymal phenotype [13,14]. Of note, the
transcriptomes of E (HP) cell-derived mammospheres did not completely convert to the tran-
scriptomes of adherent M (M4) cells but rather displayed an intermediate EM expression pat-
tern, suggesting an incomplete E to M conversion (Fig 1D). Intriguingly, the transcriptomes of
the M cell-derived mammospheres changed in the opposite direction and also converged to an
intermediate EM profile. Specifically, in M cell-derived mammospheres, expression of E-specif-
ic transcripts was increased and M-specific transcripts decreased (Fig 1D and 1E). These obser-
vations would be consistent with the notion of incomplete M to E conversion (MET) in M4
cells, and of incomplete EMT in HP cells.
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The formation of an intermediate EM gene expression pattern upon transfer from adhesion
to suspension (mammospheres) culture involved convergent gene expression shifts at two
levels: (1) at the level of E and M-specific genes, manifest in the change from anti-correlated in
adherent E versus M cells (Pearson correlation coefficient, r = -0.44) to highly correlated in
mammospheres (r = +0.82) (S2C Fig); (2) at the level of the whole transcriptome (‘all genes’)
from anti-correlated in adherent E versus M cells (r = -0.13) to correlated (r = +0.63) in mam-
mospheres (Fig 1F).
Together, our data confirm that—like in other luminal epithelial cancer cell lines –HP cells
with highest stemness induced by mammosphere formation displayed a mesenchymal gene ex-
pression program. By contrast, for M4 cells—like in basal mesenchymal cancer cell lines—the
stem-like cells enriched in mammospheres expressed more epithelial genes. Due to this con-
text-dependent increase of expression of either M or E-specific genes in mammospheres and
the incomplete transition to the opposite state the stem cell-enriched mammospheres from
both HP (E) and M4 (M) cells exhibit co-expression of both E and M genes, confirming our hy-
pothesis of stemness of the intermediate state in HMLER cell lines.
Co-expression of E and M genes predicts poor outcomes in all breast
cancer subtypes
If the mixed E and M signatures seen in the mammospheres are associated with stemness they
may be able to predict poor survival in breast cancer patients. We therefore analyzed a publicly
available database of primary breast tumors in up to 3,455 patients using the Kaplan-Meier
plotter tool [43]. We sub-classified the primary breast tumors using the St. Gallen clinico-path-
ological criteria into four breast cancer subtypes: the epithelial-like ER+ slow proliferating lu-
minal A and fast proliferating luminal B subtypes, the mesenchymal-like ER- basal and HER2
positive subtype (see methods).
To identify the intermediate E/M state, we generated an ‘EM’ signature consisting of 60
genes composed of the respective 30 most extremely expressed E and 30 M genes in HMLER
cells (S2 Table, hereafter termed ‘EM_HMLER’), as opposed to the E state described by E genes
and the M state described by only M genes alone. Intriguingly, we found that the EM_HMLER
signature predicted poor overall survival in the ‘all’ breast cancer category as well as in all four
breast cancer subtypes analyzed, which all had a high hazard ratio (HR>1), all with significant
logrank p-values except for the luminal B patients subgroup (Fig 2). Accordingly, in all four
subtypes as well as in the ‘all’ breast cancer category expression of EM_HMLER was also asso-
ciated with poor relapse-free survival that was significant for all subtypes except for the rarely
metastasizing luminal A and the HER2 subgroup. Also, the EM_lung signature (S2 Table) was
associated with poor overall survival in all breast cancer subtypes, but only had a significant p-
value for ‘all breast cancer’ and luminal B subtypes. Together, these findings suggested that
genes associated with the oppositemorphologies of E and M cell-types and not only breast-spe-
cific E and M genes are associated with poor outcomes in all breast cancer sub-types.
To compare the capability of the EM signatures with other signatures thought to be associat-
ed with poor patient outcome, we tested the proliferation-associated PCNAmetagene signature
[44] and the mammaprint 70 signature [45] (S2 Table). As expected, in the largest group of
breast cancer patients with ER+ luminal A breast cancer the PCNA metagene and mamma-
print signatures significantly predicted poor survival (Fig 2). However, unlike EM signatures,
neither of these signatures was capable to predict poor survival in all four breast cancer sub-
types. More strikingly, the PCNA metagene signature significantly predicted good overall sur-
vival in both ER- patient groups (HR<1 for HER2+ and basal breast cancer, p = 0.05 and
p = 0.01, respectively); and the mammaprint signature also significantly predicted good
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survival in basal tumors (p = 10–5). Similarly, another signature thought to be associated with
stemness, the pluripotency factor-associated signature (NANOG-, OCT4-, SOX2-activated
transcription factors, NOS-TFs)[46] also failed to predict poor survival in breast cancer, as it
was significantly associated with good survival in ‘all’ breast cancer, luminal B and basal breast
cancer patients (p = 0.05, p = 0.004 and p = 0.01, respectively). These data are consistent with
previous studies for the NOS-TFs signature showing that it did not correlate with poor
Fig 2. Co-expression of E and M genes predicts poor breast cancer patient survival. Kaplan-Meier plots showing time of overall survival (OS) and
relapse-free survival (RFS) of breast cancer patients with different intrinsic breast cancer subtypes using the indicated gene expression signatures consisting
of 60 genes (S2 Table) and the Kaplan-Meier-Plotter online tool (database 2014). Numbers of patients within tumor subtype for OS or RFS are indicated on
top. Hazard ratio (HR) and respective logrank p-values (P) that discriminate high (red line) and low (black line) expressing patient groups are shown.
doi:10.1371/journal.pone.0126522.g002
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outcome in breast cancer [46], and with previous observations that mammaprint and prolifera-
tion signatures have only been shown to be prognostic in ER+ and HER2- breast cancer sub-
types [10].
Since both the lung and the HMLER-derived E and M gene sets overlapped substantially
with the HMLER E and M gene sets, this suggested redundancy in capability of predicting poor
survival of EM signatures in breast cancer subtypes. If so, then a smaller subset of the 60
EM_HMLER genes and possibly also overlapping but not identical HMLE-derived EM signa-
tures [22] should also be capable to predict poor outcome. For these analyses we focused only
on the more aggressive ER+ subtype luminal B that most frequently metastasizes and the ER-
basal breast cancer patients, where mammaprint and PCNA metagene failed to predict poor
outcome. From our HMLER-derived E and M signatures and the previously published [22]
five different HMLE E and M signatures, we used the 12 most specific E genes and M genes
each, to compose a set of EM signatures of 24 genes, named EM_HMLER(24), EM_GSC(24),
EM_TWIST(24), EM_ SNAI1(24), EM_siCDH1(24), EM_TGF (24) (S2 Table). The results for
Kaplan-Meier analyses are displayed as HR versus logrank p-value plots for overall patient sur-
vival (S3A Fig): in basal tumors all six different EM signatures predicted poor survival
(HR>0), with four of them associated with a significant p-value. Equally, also in luminal B pa-
tients all EM signatures predicted poor survival, five of them significantly. Analysis of relapse-
free survival data (S3B Fig) confirmed the same tendency of all EM signatures to predict poor
survival in basal and luminal B tumors, and thus all of the only 24 genes comprising EM signa-
tures exceeded the prognostic value of PCNA metagene and mammaprint signatures (Fig 2) to
predict poor outcome in both ER+ and ER- breast cancer patients.
Random gene sets often also predict poor outcome, independent of their biological meaning
[44]. Therefore we tested if our results for the EM signatures could have been due to chance.
We found that, as expected, random gene sets showed similar distributions of hazard ratios<1
and>1 for overall survival in basal and luminal B patients (S3D Fig). By contrast, relative to
sets of genes randomly chosen from the whole genome and permutation analysis, all six EM
signatures still predicted poor outcome in both patient subtypes with three of them significant-
ly (S3C Fig). Finally, bootstrapping (10,000 different gene sets of 10 out of the 24 most EM-spe-
cific HMLER genes) confirmed that the majority of EM genes were associated with poor
survival in luminal B and basal patients (S3E Fig).
Together, these data showed that expression of a set of signatures composed of genes associ-
ated with the epithelial and the mesenchymal phenotypes (derived from HMLE, HMLER and
lung cancer) reliably predicted poor outcome independent of the breast cancer subtype being
ER+ or ER-, while NOS-TFs, mammaprint and the PCNAmetagene signatures were not pre-
dictive or were restricted to ER+ tumors. This suggested that the CSC population responsible
for relapse and poor survival of patients of all breast cancer-subtypes is characterized by the in-
termediate E/M state which is therefore independent of the tumor-type context.
Segregation of plasticity with epithelial cell-types and self-renewal with
mesenchymal cell-types during mammosphere formation
The above findings strongly associated a mixed E and M gene expression signature with stem-
ness and aggressiveness in luminal and basal whole-cell populations (Fig 1) and in all breast
cancer subtypes (Fig 2). To understand stem cell-relevant properties conferred by co-expres-
sion of E and M genes, we dissected which stem-like properties are associated with cells nor-
mally mostly expressing E genes versus cells expressing M genes in the mammosphere assay.
We wished to compare the capacity of ‘self-renewal’ and ‘generation of heterogeneous progeny’
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(plasticity) in genetically identical E and M HMLER cell-lines by single cell analyses using flow
cytometry and single cell qPCR analysis.
As expected, freshly FACS-sorted CD24+/CD44- cells from immune-stained HP cell popu-
lations (Fig 3A) had the typical E morphology (similar to HP cell cultures) whereas the CD24-/
CD44+ cells had Mmorphology as observed by light microscopy (Fig 1A). The sorted subpop-
ulations appeared to be stable as more than 88% of the cells remained within their respective
CD24/CD44 quadrants after 10 days of re-culturing in adhesion and mostly resembled the sin-
gle cell-derived E and M clones with respect to CD24/CD44 expression (Fig 3B and S1 Fig), but
also both of them could slowly regenerate the opposite cell-type (Fig 3B).
In mammosphere assays not only cells from the E and M clones but also freshly sorted
CD24+/CD44-(E) and CD24-/CD44+(M) cells could form sphere-like aggregates which were
capable of survival and proliferation because carboxyfluorescein diacetate succinimidyl ester
(CSFE)-labeled and sorted E and M cell-types both lost their CSFE label during mammosphere
culture (S4A Fig). To compare E and M cells with respect to the stemness properties, plasticity
and/or self-renewal, we analyzed single cell suspensions of dissociated mammospheres for
CD24 and CD44 expression. Most cells of both freshly sorted CD24+/CD44-(E) cells and the
E-clones had nearly completely converted to the CD24-/CD44+(M) state under mammosphere
conditions (Fig 3C and S4 Fig), suggesting a high phenotypic plasticity of E cells. Conversely,
M cells were significantly less plastic because neither freshly sorted CD24-/CD44+(M) cells nor
cells fromM clones had converted to the CD24+/CD44-(E) state in suspension mammosphere
conditions (Fig 3C and S4 Fig). Consistent with the surprising low plasticity of CD24-/CD44+
(M) cells in mammospheres, all five single cell-derived M clones lacked the capacity to generate
a distinct CD24+/CD44-(E) population even when grown in adhesion for 5 passages (Fig 3B
and S1 Fig) or 20 passages (data not shown). By contrast, in line with the high plasticity of E
cells seen in mammosphere cultures, most E clones spontaneously re-established a small but
stable CD24-/CD44+(M) subpopulation upon passaging in adhesion conditions within about 5
passages, establishing a heterogeneous culture that resembled the parental HP cell population
as was previously reported for less transformed HMEC-derived HME cells [36].
Independent of the cell of origin (E or M clones, or freshly sorted E and M cells) the vast
majority (65%-95%) of cells growing in suspension as mammospheres were CD24-/CD44+(M)
cells (Fig 3C and S4 Fig), while cells in the CD24+/CD44-(E) state were usually not detected as
has also been observed in primary breast tumor cells [42]. Thus, while the CD24+/CD44-(E)
cells appeared highly plastic, the CD24-/CD44+(M) phenotype was not plastic, but by contrast
had a proliferation advantage in suspension, indicating ‘self-renewal’ capacity with respect to
its CD24/CD44 phenotype. Therefore, in the transition from adhesion to mammosphere cul-
ture, the stemness traits ‘plasticity’ and ‘self-renewal’ are uncoupled and segregate with either
the CD24+/CD44-(E) or the CD24-/CD44+(M) phenotypes, respectively, challenging the
widely held notion that the M phenotype but not the E phenotype embodies stemness.
Single cell qPCR analysis reveals existence of CD44+ hybrid E/M cells
in E and M cell-derived mammospheres
The enrichment for CD24-/CD44+ cells in mammospheres (Fig 3C) would suggest that the
vast majority of cells in suspension cultures became ‘mesenchymal’ which is in conflict with
the mammosphere transcriptome data (Fig 1D). This raised the possibility that cell-surface ex-
pression of CD24 and CD44 markers may not accurately reflect the E versusM duality. Since
promiscuous gene expression within a cell is often a hallmark of stemness, we next considered
the appearance ‘hybrid E/M cells’ not with respect to cell surface CD24 and CD44 expression
but to a set of RNA-expression of E and M-specific genes. This could account for the increase
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Fig 3. Single cell analysis of EMT and MET state transitions duringmammosphere formation. (A) Flow cytometry profiles of the expression of CD24
and CD44 cell surface antigens in adherent grown parental HMLER (HP) cells. Cells were sorted from the indicated gates and (B) cultured in adhesion until
confluence or (C) as mammospheres for two weeks in suspension. Cells were individualized, stained for CD24 and CD44 and again analyzed by flow
cytometry. Data shown are from biological duplicates and are representative of at least three independent experiments. (D) Heat map of single cell qPCR
analysis (BioMark Fluidigm) from sorted cells of E (HP, E5) and M (M4, M5) populations under adherent and mammosphere conditions for two days (2d) and
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of E gene expression in transcriptomes of the M clone-derived mammosphere that contained
apparently homogenous CD24-/CD44 cells. Thus, we performed single cell qPCR analyses [47]
to simultaneously measure the transcript levels of E- and M-specific genes in the E cell-lines
(E5 and HP) and M cell-lines (M4 and M5 clones). We selected 10 E-specific and 11 M-specific
genes from our differentially expressed predictive signatures (Fig 1, S1 and S2 Tables) that had
a relatively high baseline expression to facilitate detection on single cell level but also included
genes that were previously reported to be characteristic of E (CDH1, EPCAM,CD24) or M cells
(CDH2, FN1, VIM, CD44) as well as other genes previously associated with stemness (S5 Fig
and S4 Table).
As expected, in adherent cultures all individual E genes were higher expressed in individual
E cell-types while most M genes were higher expressed in M cell-types (Fig 3D). Interestingly,
some of previously reported genes to be M-specific were only occasionally (FN1, CDH2) or not
at all (CD44, SNAI1) characteristic for M clones in whole transcriptomes of sorted small cell
pools (100 cells) of adherent E versus M cells, nor did their expression show a larger than
2-fold difference between individual morphologically E and M cells (S5 Fig). Therefore, we fo-
cused on 7 M-specific genes (ABCA6, DCN, IL1R1, PCOLCE,WNT5A, VIM, ZEB2) most of
which were also contained in the predictive HMLER_EM signatures (S1 and S2 Tables). Inter-
estingly, the M genes DCN, IL1R1, PCOLCE and VIM were also expressed in some individual E
cells. By contrast all ten E genes selected based on whole population transcriptomes (CDH1,
CD24, EPCAM, IL1B, KRT5, LCN2, TP63, TRAIL, SLPI, S100A8) were exclusively expressed in
E cells (with exception KRT5 in 1 of 24 M cells) confirming their identity as E genes at the sin-
gle cell level.
To assign the degree of E and M phenotype in individual cells, the transcript levels of all
tested 10 E and 7 M-specific genes, measured by single-cell qPCR, were summarized by pro-
jecting each cell into a position in an E-M state space, spanned by the E and M axes which rep-
resent the aggregate normalized expression value of these E or M-specific genes, respectively
(Fig 3E, see Experimental Procedures for details). In adhesion culture, E cells displayed sub-
stantial M-gene expression as manifest by their position closer to the diagonal: 22 of 24 E cells
co-expressed E and M genes. This promiscuity of the nominal E cells was consistent with the
high plasticity of E cells (Fig 3C). By contrast, 23 of 24 M cells exclusively expressed M-genes,
which was on average 10-fold higher than in E cells. Therefore, M cells showed barely any over-
lap with HP or E5 cells in the E-M state space (p = 2.410–5, cross-match statistical test, see S5
Table and S1 Methods). Consistently, in analogy to their similar cellular morphology and
CD24/CD44 expression in adhesion 12 HP and 12 E5 cells (p = 0.23) as well as the 12 M4 and
the 12 M5 cells (p = 0.23) were not discriminable using the same markers. Thus our data con-
firmed good reproducibility of the cells’ state in the E-M state space for different HMLER cell
lines, independent of clonal variations.
When grown as mammospheres, the average expression values (crosses in Fig 3E) of disso-
ciated cells in all the analyzed cell-lines shifted toward the diagonal and showed similar expres-
sion patterns, suggesting a hybrid gene expression state in the E-M state space compared to the
respective adherent E and M cell populations (Fig 3F). A correlation plot of all 46 analyzed
genes in individual cells confirmed that mammospheres could indeed be seen as heterogeneous
three weeks (3w), using E and M-specific genes. Columns represent individual cells. Gene expression measured below background is shown in gray. (E)
Mean expression per cell of 10 E-specific (CDH1, CD24, EPCAM, IL1B, KRT5, LCN2, TP63, TRAIL, SLPI, S100A8) and 7 M-specific genes (ABCA6, DCN,
IL1R1, PCOLCE,WNT5A, VIM, ZEB2) in the E/M state space of individual cells grown in adhesion and three weeks as mammospheres (F). Crosses indicate
mean expression of all 12 measured cells. P-values between the indicated groups of cells were determined using a cross-match test to discriminate by mean
of E and M gene expression (S5 Table). Results with respect to statistically significant difference between gene expression in adherent E and M cells were
observed in three independent experiments for single cells as well as well as for 100 cell pooled samples.
doi:10.1371/journal.pone.0126522.g003
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intermediate between the E and M state (S2D Fig). Specifically, in mammospheres we could
distinguish two types of cells in the E-M state space: one type expressed only M genes, similar
to adherent M clones; the other type on the diagonal showed the intermediate E/M transcript
pattern. This hybrid E/M state was the collective result of individual cells in the mammo-
spheres displaying ‘spotty’ expression of few individual markers of the opposite type (Fig 3D
and 3F). The difference of gene expression pattern between the 24 adherent M cells and the
24 mammosphere-derived M cells was significant (p = 0.014) as was the difference between the
24 adherent E cells versus 24 mammosphere-derived E cells (p = 0.014). By contrast, within
this same scheme of aggregating E and M gene expression value alone we could not discrimi-
nate between E- and M-derived cells anymore (p = 0.3) once the cells had grown as mammo-
spheres (S5 Table), consistent with the convergence to the intermediate state we had observed
in whole population arrays (Fig 1D and 1F). These data also demonstrated that some E cells
could undergo complete EMT towards a state resembling differentiated M clones since they
moved to the position of the ‘pure’ adherent M cells in the E-M state space, underscoring the
plasticity of E5 and HP cells. Since M clones could express only one or two individual E genes
in a few cells (Fig 3D) but they never converted to ‘pure’ E cells, this may suggest a proclivity to
‘incomplete’ or ‘partial’MET during mammosphere formation.
In conclusion, single cell qPCR analysis and the projection into the E-M state space revealed
the existence, in the aggregate, of hybrid E/M cells in mammospheres of all examined E and M
cell-lines. Thus, the presence of hybrid E/M cells in mostly CD44+ cells-containing mammo-
spheres explained why CD44 expression can both be associated with the EM state (in mammo-
spheres) and with the M state (in adherent M clones).
Co-culture of E and M cell-types synergistically increases
mammosphere formation and self-renewal
The increased stemness and aggressiveness associated with co-expression of E and M signa-
tures in luminal B and basal breast tumors (Fig 2) and of mammospheres derived from E and
M cell-lines (Fig 1) can in principle result from one or both of two scenarios: (1) from a hetero-
geneity of cell composition, i.e.,mixture of E and M cells, or (2) from the hybrid E/M cells
(Fig 3F) due to co-expression of E and M genes within the same cell.
We first determined whether cooperation of E and M cells, the first scenario, per se can pro-
mote stemness which would explain its tight association with aggressiveness. Indeed, co-cultur-
ing of either E5 with M5 cells or of freshly sorted CD24+/CD44-(E) with CD24-/CD44+(M)
cells substantially increased sizes (Fig 4A) and numbers (Fig 4B and 4C) of mammospheres
compared to E cells or M cells cultured alone. In the mixed E+Mmammosphere assays, mam-
mosphere numbers were increased by two to six-fold relative to an expected additive effect. We
observed this synergistic effect also when the total number of seeded cells was the same in the
E+M co-culture as in the single cell-type cultures (Fig 4B). To test if co-presence of E and M
cells in these mammospheres also resulted in increased self-renewal [11], we dissociated the
mammospheres and generated ‘secondary’mammosphere from 10% of the cells of the ‘prima-
ry’mammosphere cultures. Indeed, the number of secondary mammospheres generated from
cells derived from E5+M4-mammospheres was 10-fold larger compared to secondary mam-
mospheres generated from cells derived fromM4-mammospheres (Fig 4D). By contrast, mam-
mospheres generated from E5 cells alone did not give rise to any secondary mammospheres.
Thus, mixing populations of E+M cell-types can robustly increase mammosphere formation,
indicative of cooperation between E and M cells that increases stemness trait of mammosphere
formation and self-renewal. This suggested that E or M cells growing alone represent more
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‘differentiated’ populations compared to E-M co-cultures which promote the ‘de-differentia-
tion’ to a stem-like state.
Our observations of E-M cooperation are consistent with in vivo studies in which xenograft
transplantation of a mixture of E and M cancer cells in mice produced more metastatic tumors
than injection of pure cell populations alone [25,27] and with a recent study showing cooperat-
ing luminal and basal breast tumor subclones [48].
Single CD24+/CD44+ cells are hybrid E/M cells and show increased
stem-like properties
To investigate whether the hybrid E/M state of the second scenario indeed represents increased
stemness in HMLER cells, we took advantage of the fact that at later passages of HP cells (des-
ignated ‘HP_late’) with more balanced percentages of E and M cell populations showed a spon-
taneous distinct ‘double-positive’ CD24+/CD44+ subpopulation (Fig 5A, 30% CD24+/CD44-
(E) cells, 51% CD24-/CD44+(M) cells, and 8% CD24+/CD44+ cells). These CD24+/CD44+
cells also sometimes spontaneously appeared in both E and M clones when passaged under
Fig 4. Co-culture of E and M cell-types synergistically increases mammosphere formation. (A)
Representative light microscope images (10x objective) from mammospheres of 500 E5, 500 M5, and 500
E5 + 500 M5-derived mammospheres after two weeks suspension culture. (B) Total number of primary
mammospheres derived from 500 (1x) or 1000 (2x) cells per cell-type seeded (from A) after two weeks
suspension culture. (C) Total number of primary mammospheres grown from 500 (1x) freshly sorted
CD24+/CD44-(E) cells, 500 CD24-/CD44+(M) cells, the co-culture, or 500 un-gated HP cells (‘all HP’) after
two weeks of mammosphere formation. (D) Relative number of primary (seeded 2,000 cells per cell line per
well) and secondary mammospheres from M4 grown with or without E5 cells or HP cells. After two weeks
10% of total number of dissociated cells from the indicated primary mammosphere samples were reseeded
for secondary mammospheres and counted after one week. Mammospheres per well relative to that of
M4-derived spheres are shown.
doi:10.1371/journal.pone.0126522.g004
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adhesion conditions (S6 Fig) and thus their origin in the mixed HP populations remained un-
clear. We hypothesized that these CD24+/CD44+ cells represented an intermediate state be-
tween E and M cells, and thus, a possible subset of the hybrid E/M cells which could be
functionally examined for stem-like properties by cell-sorting.
Fig 5. CD24+/CD44+ cells are hybrid E/M cells and have increased stem-like properties. (A) CD24/CD44 flow cytometry profile of HP_late cells. (B)
Single cell qPCR analysis of 20 individual cells sorted from each of the six indicated CD24/CD44 subpopulations (from two independently passaged HP_late
cell-lines). Mean expression of 10 E and 7 M genes (as in Fig 3) is visualized in the E-M state space. The crosses mark the average expression within the
three different CD24/CD44 subpopulations (40 cells). Indicated p-values were determined using a cross-match test by comparing mean of E gene expression
and/or M gene expression between indicated groups of single cells (S5 Table). (C) Principal component (PC) projections of the 120 individual cells as tested
in (B) for the three different subpopulations colored according to their CD24/CD44 origin are shown. (D) PC loading projections of the 48 genes as tested in
(B), showing the contribution of each gene to the first two PCs. E genes are colored in orange, M genes in blue, pluripotency genes in green, and
housekeeping genes in black. (E) CD24/CD44 flow cytometry analysis of cells cultured under standard adhesion conditions for 10 days that had been freshly
sorted from 100 cells of the three subpopulations from (A). (F) Assessment of ALDH1 activity in cultured cells derived from the three subpopulations (E) using
the ALDEFLUOR assay. Gate shows percentage of ALDH1+ cells. Small insets show the negative control cells incubated with DEAB. (G) Mammosphere-
forming ability per 1,000 sorted cells of the three HP_late derived cell populations (A) after two weeks in suspension.
doi:10.1371/journal.pone.0126522.g005
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From each of the three FACS-sorted subpopulations (CD24+/CD44-, CD24+/CD44+ and
CD24-/CD44+) from two independent HP_late cell-lines grown in adherence, we sorted 20 in-
dividual cells, using the FACS gates shown in Fig 5A, and analyzed 48 different transcripts
using single-cell qPCR (S6 Fig). Examined genes included not only the E and M genes but also
embryonic stem cell associated genes (POU5F1, SOX2, NANOG) as well as other genes express-
ed in breast cells (S4 Table, S6 Fig). First, we again projected the aggregate expression pattern
of each cell into a position in the E-M state space (Fig 5B). Consistent with their expected E or
M states, respectively, CD24+/CD44-(E) cells were in the upper left part of the E-M state space,
and CD24-/CD44+(M) cells in the lower right part of the E-M state space with barely any over-
lap (1E cell in the M state and 3M cells in the E state space). Indeed, the CD24+/CD44+ dou-
ble-positive cells occupied an intermediate state in the E-M state space along the diagonal,
with about half of the cells in the E region, overlapping with CD24+/CD44-(E) cells and the
other half in the M region, overlapping with CD24-/CD44+(M) cells. The difference between
CD24+/CD44- and CD24-/CD44+ cells with respect to their position in the E-M state space
was highly significant (p<10–6). Also, double positive cells were significantly different from
CD24+/CD44-(E) cells (p = 10–5) but resembled more CD24-/CD44+(M) cells (p = 0.35 when
using a cross-match test for both E and M genes, but p<0.004 using E or M gene sets alone in a
Mann-Whitney U test, Fig 5B and S5 Table). By contrast, as expected, between the two inde-
pendently passaged HP_late cell-lines CD24+/CD44-(E) cells, CD24+/CD44+(E/M), or
CD24-/CD44+(M) cells were much more similar to cells with the same surface markers
(p = 0.6, p = 0.9, p = 0.3,respectively, S5 Table), suggesting a good reproducibility of biological
replicates for their positions in the E-M state space. Thus, the opposite expression patterns of
CD24 and CD44 as the CD24+/CD44- and CD24-/CD44+ constellations in individual HP_late
cells can accurately describe the E versus M dualism when both markers were simultaneously
expressed in a population, and double positive cells could be discriminated to some degree as a
distinct subpopulation from the CD24+/CD44- and CD24-/CD44+ cells.
Principal Component Analysis (PCA) of the 48-gene profiles of the individual cells confirmed
the intermediate position of the CD24+/CD44+ cells population between the E and M cells with
respect to the second component (PC2), thus confirming that individual CD24+/CD44+ cells
were in a hybrid E/M state (Fig 5C). The nearly complete segregation of E genes and M genes in
the second component confirmed our previous choice of E andM genes to discriminate between
the most distinct cell-types in HMLER cells (Fig 5D and S6 Fig).
To compare the stemness capacities of these three cell-types we expanded the sorted popula-
tions for one week in adhesion culture. Both, the CD24+/CD44-(E) cells and CD24+/CD44+
(E/M) cells were highly plastic, since they both gave rise to the more extreme E and M cells
(Fig 5E). However, CD24+/CD44- cells were more stable (remaining 65% CD24+/CD44- cells)
while only 11% CD24+/CD44+ cells persisted for 10 days in adhesion. Accordingly, ALDH1
activity, a marker for stemness in many tissues [49], was highest in the CD24+/CD44+(E/M)
and CD24+/CD44-(E) cells (7.0% or 5.7%, respectively) (Fig 5F) while low (0.6%) in the
CD24-/CD44+(M) cells which, as expected did not display phenotypic plasticity (Fig 5E).
Thus, capacity to generate ALDH1+ progeny segregated with phenotypic plasticity. Remark-
ably, CD24+/CD44+(E/M) cells formed mammospheres with at least nine-fold higher efficien-
cy than either sorted E or M cells alone (Fig 5G).
Taken together, these results show that CD24+/CD44+ double positive cells are (1) indeed
hybrid E/M cells with respect to expression of multiple E and M genes and (2) exhibit stem-like
character, including a substantially higher mammosphere forming capacity relative to the
other more pure differentiated E and M populations, and more ALDH1+ progeny. Thus,
CD44+ expression state can either be associated with stemness and the hybrid E/M state or
with a more differentiated and more pure M state. Consistent with our data, in other tumor
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cell-lines derived from breast [50] and of other tissues [51,52] the CD24+/CD44+ cell subpop-
ulation has previously been associated with a CSC-enriched phenotype due to increased tumor-
igenicity in mice.
Discussion
Our results suggest that the co-expression of E and Mmarkers in breast cancer at the whole-
tumor level, producing an intermediate pattern between E and M, might scale with the stem-
ness character, thereby accounting for its association with poor outcome (Fig 2). Here we show
experimentally the two reasons that explain this relationship: First, the mixture of cells in the E
and M states promotes stemness (measured as mammosphere formation) through the inter-
cell cooperation between these two distinct cell-types (Fig 4); and second, the co-expression of
E and M genes in the very same cell, which we call here hybrid E/M cells (Figs 3 and 5) also
promotes stemness and mammosphere formation. While either one of these two scenarios in
itself would result in the apparent intermediate E-M expression signature in the entire tumors,
they are intertwined in that the former, cooperation, promoted the latter, stem-like hybrid cells
(Figs 3 and 4). Of note, also vice versa some hybrid E/M cells (CD24+/CD44+) but not E clones
(also individually co-expressing E and M genes, Fig 3E) could promote E-M cell cooperation in
proliferating populations (Fig 5E and 5G), suggesting that not only RNA but also protein ex-
pression of both epithelial (e.g. CD24) and mesenchymal (e.g. CD44) states is necessary for
mammosphere formation.
The interaction of both mechanisms for producing the intermediate E/M gene expression
signature, cooperation and the presence of hybrid E/M cells may account for the robustness
with which E/M co-expression predicts poor outcome in both ER+ and ER- breast cancer – to
our knowledge the first gene expression signature that predicts outcome independent of
tumor- subtype in breast cancer (Fig 2). Intriguingly, the predictive potential of our EM signa-
ture (suggestive of stemness) outperformed other signatures previously associated with poor
outcome in breast cancer, such as signatures reflecting proliferation (PCNA-metagene and
mammaprint) or those containing embryonic stem cell-associated transcription factors
(NOS-TFs). These observations are consistent with the recent findings that alternative lineage
specifiers can replace OCT4 and SOX2 in the reprogramming of human fibroblasts [53] con-
firming they can be encoded in a distributed manner –through promiscuous expression
patterns.
Our data provide an explanation for a series of paradoxical reports on the role of E and M
gene expression in CSCs in vitro and in vivo (Fig 6A): in luminal epithelial cell lines, stemness
and CSC have been linked to expression of M-specific genes [15]; conversely, in basal mesen-
chymal cell lines stemness has been associated with expression of E genes [20,23–25]. Our re-
sults support a new testable breast CSC model (Fig 6B) that is consistent with our hypothesis in
that the postulated small subpopulation of CSCs resides in the intermediate hybrid E/M state,
independent of the tumor and cell-line context (luminal epithelial and basal mesenchymal
breast cell lines and luminal ER+ and basal ER- tumors): stem-like hybrid E/M cells can arise
in both the E and M cell populations through incomplete EMT and MET, respectively. This de-
parts from the paradigm in which CSC are the result of the process of EMT [13,14].
Our CSC model, experimentally supported and consistent with clinical data, is in line with
previous theoretical work that postulate an intermediate E/M state [5,28,29,54–56] and its as-
sociation with stemness. These studies suggested that the hybrid E/M state arises in a dynam-
ical fashion as a (meta)stable attractor state in a gene regulatory circuit composed of mutually
inhibitory circuits of miR-34/SNAI1 [54,56], miR-200/ZEB [28,56], or LIN28/let7 [55], with
intermediate levels of both miR200 and ZEB or LIN28 and let7 characterizing the intermediate
Stemness of the Epithelial/Mesenchymal State in Breast Cancer
PLOS ONE | DOI:10.1371/journal.pone.0126522 May 28, 2015 16 / 28
stem-like hybrid E/M state, similar to the negative feedback loops seen in other decisions at
branch points in cell development [57]. Furthermore, the LIN-28/let-7 circuit connects the in-
termediate hybrid E/M state with expression of intermediate, stemness-associated levels of the
pluripotency factor POU5F1/OCT4 [58]. However these models do not consider cell popula-
tion heterogeneity and ensuing heterotypic E-M cooperation which introduces a non-cell au-
tonomous element in cell-state dynamics which, as we have shown, affords additional stability
to the hybrid state. Given the key role of miRNAs in these models, extracellular presence of
mir-200 or let7 could be a key component of this cooperation.
We found in our in vitromodel that M clones were irreversibly locked in a more mesenchy-
mal and less plastic state compared to E-cell-types both in adhesion (S1A Fig) or suspension
cultures (Fig 3 and S4B Fig). This is supported by reports that TGFβ-treated MCF10A cells un-
dergo an irreversible switch to the M-state regulated by the miR-200/ZEB circuit [29,56]. By
contrast, MET has been observed during reprogramming of fibroblasts [59,60] but in the ab-
sence of single cell resolution data using appropriate markers it remains unclear whether MET
was partial or complete in these studies. However, a hidden potential to undergo MET may
Fig 6. The conventional versus a new integrative CSCmodel for breast cancer. (A) In luminal epithelial cell-lines (e.g. in HMLE, HMLER, MCF7) the
conventional model describes breast CSCs as M cells and ‘non cancer stem cells’ as E cells. Paradoxically, in more basal mesenchymal cancer cell-lines
(MDA-MB231 cells, MCF10ACA1, 4T1) the more E gene-expressing cells are associated with CSC-properties. Thus, the identity of CSCs appears to be
context-dependent. (B) Our model for CSCs integrates and explains these paradoxes by the existence of stem-like intermediate hybrid E/M cells
independent of the tumor cell line. We propose that compared to more ‘polarized’ differentiated E (capable of plasticity) and M cell-types (capable of self-
renewal), undifferentiated hybrid E/M cells can generate more mammospheres and heterogeneous progeny due to their capacity of both, self-renewal and
plasticity. Arrows indicate possible state transitions (incomplete EMT and MET) between the instable hybrid E/M state and the extreme stable E and M states.
Stemness of the intermediate E/M state is reflected both by presence of stem-like hybrid E/M cells and by co-presence of E and M cell-types due to
cooperation. Context-independency of the stemness of the intermediate E/M state explains the paradoxical context-dependent meaning of E genes in basal
tumors and M cell lines and stemness of M genes in luminal B tumors and E cell-lines (A).
doi:10.1371/journal.pone.0126522.g006
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depend on the respective cells, their underlying epigenetic state and could be unleashed in few
individual cells by genetic manipulation with inducing factors, such as transduction with vec-
tors encoding pluripotency factors [61] and subsequent selection. In accordance with our
model, the irreversibility of the pure M state after complete EMT as well as stemness of the in-
termediate state was also suggested in a very similar, independently developed ‘gradient EMT
model’ which also assumes that cells that had differentiated to the mesenchymal state are more
committed and thus less plastic than E cells or hybrid E/M cells [62].
Our experimental data suggest that compared to the hybrid E/M state the more differentiat-
ed E and M cells still exhibit aspects of stemness which are distinct in these two cell-types: we
found that cells expressing E genes exhibited phenotypic plasticity while cells expressing M
genes displayed self-renewal in suspension to cells (Fig 3). Expression of either set of genes
alone correlated with less mammosphere formation capacity than co-expression of E and M
genes. This confirms that the “extreme” E and M states represent two distinct “differentiation
states” relative to the stem-like intermediate E/M state. The complementarity of plasticity and
self-renewal (both of which are necessary characteristics of stemness) may underlie the syner-
gism between E and M cells in mammosphere formation (Fig 4). It is likely that complex and
possibly highly redundant mechanisms involving cell-cell communication play a role in the co-
operation between E and M cells due to the redundancy in EM signatures to predict poor out-
come (Fig 2 and S3 Fig). The central role of such cooperation is manifest through
complementary expression of E and M cytokine and their cognate receptor pairs on E and M
cells (or vice versa), such as IL1B (E cells) and IL1R1 (M cells) (S5B Fig) and in many other het-
erotypic E and M cell interactions relevant during embryogenesis [63]. Complicating the sim-
ple notion of a symmetric dualism of the E and M type cells, we note that despite the obvious
distinction between these cell states in terms of morphology (which was strongly correlated
with the mirror CD24+/CD44- and CD24-/CD44+ surface marker status), analysis of single
cell transcript patterns suggests that the majority of E cells also express components of the M
cell program (Fig 3E), in line with their higher plasticity compared to M cells (Fig 3B and 3C).
A recent study on primary tumors and tumor cell lines demonstrated that CSCs are either
generated by EMT or MET [34] which is consistent with our experimental data comparing ad-
herent cells versusmammospheres which could be generated by EMT or MET (Fig 1D–1F).
However, Liu et al also demonstrated that the CSCs characterized either by expression of the
mesenchymal marker CD44 or by the epithelial and stemness marker ALDH1 can exist in two
distinct gene expression states overlapping in only a few expressed genes. This seems contra-
dictory to our finding of a hybrid E/M stem-like state that can arise from E or M state. Howev-
er, since ALDH1+ and CD44+ cell populations are only enriched for CSCs but do not represent
pure CSC populations and thus also contain bulk non-CSCs, the non-overlapping portion of
the gene expression profiles of these two populations could be explained by the bulk non-CSC.
In conclusion, our work suggests that co-expression of the E and Mmarkers in tumors is
the manifestation of both cellular heterogeneity due to co-presence of cooperating E and M
cells, as well as co-expression of E and M-specific genes in the stem-like hybrid E/M cells. Al-
though the experiments were performed solely in HMLER cells, chosen for their intriguing and
well-trackable dynamics between the E and M states within a single cell line, our findings erect
a general principle for the relationship between E and M-state that for the first time explains
observations in cancer-derived cell lines, in animal models as well as tumor transcriptomes of
breast cancer patients.
In vivo, variations in populations of circulating tumor cells (CTCs) ranging from E over hy-
brid E/M to M states have been observed and are found to form in highly tumorigenic [64] cell
clusters of mixed cell-types [65]. In addition, human breast tumor-derived CTCs co-expressing
E and M protein markers, such as EPCAM and CD44 have been shown to initiate metastases
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in mice [66]. Together with our data these observations suggest that co-expression of E and M
signatures can serve both as markers for aggressiveness in whole breast tumors as well as in in-
dividual CTCs. Finally, since the metastatic ability appears to be an inherent property of all
breast tumor subtypes [45], and is linked to the apparent intermediate E/M signatures, on can
envision that dual therapeutic targeting of both the E and Mmarkers represents the targeting
of both key elements, hybrid E/M cells and the E-M cell cooperation which may improve sur-
vival of all cancer patients independent of breast tumor-subtypes.
Experimental Procedures
Cell culture
The mammary epithelial cell (HMEC)-derived HMLER cells were kindly provided by Robert
A. Weinberg (Whitehead Institute). ‘HP’ cells are defined here as a parental HMLER popula-
tion that ranged between 5% and 30% CD24-/CD44+(M) cells, while later passages with>30%
M cells were designated ‘HP_late’ cells. HP cells and single cell-derived E and M clones were
cultured under serum-free standard cell conditions in a 1:1 mix DMEM (Life Technologies)/
MEGM (Lonza). Cells were passages twice a week using trypsin which got inactivated by wash-
ing with 10% FBS. Mammospheres were generated as described [11]. Briefly, cells were enzy-
matically (30min trypsin) and mechanically detached and dissociated, and between 2,500 to
10,000 cells/ml (clonogenic densities, except Fig 4D) were either sorted or seeded into ultra-
low attachment plates (Corning) and cultured for 2 to 3 weeks in DMEM/MEGM supple-
mented with 1x B27 (Life Technologies) and 1% methylcellulose (viscosity 4,000cP, Sigma).
Imaging
Cells were photographed on a Leica DM IL LED instrument (Leica) with a DFC345 FX camera
or on a DeltaVision Core (GE Healthcare).
Gene expression arrays and gene sets
RNA of adherent growing cells was isolated by lysing adherent PBS-washed cells by addition of
TRIzol (Life Technologies) in the dish and purified according to the manufacturer’s instruc-
tions. Suspension cultures were washed with PBS and pellets were lysed by addition of TRIzol
and rigorous pipetting. RNA was purified by standard ethanol precipitation followed by addi-
tional purification using the RNeasy micro kit (Qiagen). Integrity of RNA was verified by a
2100 Bioanalyzer instrument (Agilent), and only RNA with a RIN>8 was used for subsequent
microarray analyses. 50 ng to 100 ng RNA was labeled using the one color Low Input Quick
Amp Labeling Kit (Agilent), and labeled probes were run on Human 4x44K Microarrays
(Agilent) according to the manufacturer’s instructions. Spot quantitation was performed using
Agilent’s Feature Extractor software and all data were then entered into a custom-designed da-
tabase, SLIMarray (http://slimarray.systemsbiology.net), and then uploaded into Genedata An-
alyst 7.0 (Genedata, Basel, Switzerland). Data normalization was performed in Genedata
Analyst using central tendency followed by relative normalization. Transcripts showing differ-
ential expression (p value< 0.01) between two different morphological phenotypes (E clones
E1, E2, E3, E4, E5, E6 and M clones M2, M3, M4, M5) were identified by Limma and ranked
according to their ‘effect size‘. The complete microarray dataset has been deposited in NCBI’s
Gene Expression Omnibus and is accessible through GEO accession number GSE66527.
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Patient classification and Kaplan-Meier survival analysis
Using the ‘Kaplan-Meier Plotter’ online tool (http://kmplot.com/analysis/) and the 2014 data-
set comprising up to 3458 total patients (1115 patients for ‘overall survival data’), we subdi-
vided patients into four clinically relevant intrinsic subtypes based on the St. Gallen criteria
using bimodal expression of estrogen receptor (ER, ESR), expression of HER2 (HER2), and the
proliferation marker Ki67 (MKI67) into luminal A (ESR+,HER-,MKI67low), luminal B (ESR+,
HER2-,MKI67high and ESR+,HER2+), basal (ESR-,HER2-) and HER2+ (ESR-, HER2+) pa-
tients [43]. The following probes and cutoffs were used [67]: ESR probe 205225_at (cutoff
500), MKI67 probe 212021_s_at (cutoff: 470), and HER2 probe 216836_s_at (cutoff: 4800).
Hazard ratio (‘HR’, within 95% confidence intervals) and logrank p-values (Cox’ propor-
tional hazard ratio analysis) for overall survival of breast cancer patients [43] was determined
by using the mean expression of the indicated E and M signatures (for gene lists see S2 Table).
We chose the ‘autoselect best cutoff’ option for subdividing gene expression in primary tumors
by median, quartile or tertile expression, and ‘JetSet best probe set’ [68] options to assess the
hazard ratio and logrank p-value for overall or relapse-free survival.
Immunofluorescent staining and flow cytometry analysis
Adherent cells or mammospheres were trypsinized and mechanically disrupted to generate sin-
gle cell suspensions. For CD24/CD44 profiling cells were stained with antibodies (αCD24-PE:
clone ML5, αCD44-FITC or αCD44-APC: clone G44-26, BD-Biosciences), that were diluted
1:25 in DMEM supplemented with 2% FBS. To discriminate apoptotic cells before sorting for
qPCR analyses, cells were incubated with AnnexinV/FITC and propidium iodide (PI) (apopto-
sis detection kit, BioVision). For detection of active ALDH1 single cell suspensions were sub-
jected to the ALDEFLUOR assay (Stem Cell Technologies) with diethylaminobenzaldehyde
(DEAB)-treated cells as control, as recommended by the manufacturer. Flow cytometry data
acquisition was performed on a FACSAria II SORP (Becton Dickinson) and analyzed with
FlowJo software (Tree Star, vX.0.6). To determine the CD24/CD44 quadrants in the clones and
mammosphere derived cell populations we simultaneously stained parental HMLER cells as a
reference to discriminate between the opposite CD24+/CD44- and CD24-/CD44+ populations,
and used the same gates for all cells stained and measured at the same time. All data shown are
representative of at least two experiments performed in duplicates.
Cell sorting and single cell qPCR analyses
Only singlet cells of equal FSC/SSC morphologies within the middle of the respective fluores-
cent gates were sorted. Cells were sorted directly into 96 well-plates and cultured in suspension
or adhesion conditions. For qRT-PCR analysis of single and 100 AnnexinV-/PI- (= live) cells
were sorted into wells containing Taqman primers and Cells Direct One-step RT-PCR and
pre-amplification mix (Life technologies) according to the Fluidigm single cell protocol using
18 cycles of preamplification. Gene expression was analyzed on a BioMark instrument (Bio-
Mark HD system, Fluidigm) using 48.48 Dynamic Array IFC chips (Fluidigm).
Single cell data processing
Measured Cq (Ct) values were transformed into linear expression values according to Fluidigm
protocol (Single cell application analysis): expression value = 2Log2Ex with Log2Ex = Cbg – Cq
with estimated background Cbg from reported Cq values of no template control (NTC) reac-
tions. Reported maxima were verified not to be outliers. Non-detected data (Cq≧Cbg) were set
to 0. Expression data was normalized to the maximum measured for the same gene across all
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single-cell samples. To plot single cell gene expression values into the E-M state space (Figs 3E,
3F and 5B), normalized expression values per single cell were averaged for all 10 E genes
(‘mean E genes’) or 7 M genes (‘mean M genes’) and displayed as ‘aggregate’. For PCA analyses
(Fig 5C and 5D) we used a total of 267 single cells which contained the three different subpopu-
lations (HP_late 1 and HP_late 2) and about equal amounts of E and M cell-types (including
clones, not shown). Each gene expression was centered to have a mean of zero and scaled to
have a variance of 1. We then used the R function PRCOMP to determine PC scores and PC
loading for the three subpopulations in HP_late populations. Raw Ct values for single cell data
shown in Fig 3 are shown in S6 Table and for Fig 5 in S7 Table.
Supporting Information
S1 Methods.
(DOCX)
S1 Fig. (Related to Fig 1): Generation of epithelial (E) and mesenchymal (M) single cell-de-
rived clones from HMLER cells. (A) Single cell sorting of parental HMLER cells generated
morphologically stable E and M clones. Cells were expanded in adhesion under normal culture
conditions. Characteristic CD24/CD44 FACS profiles of clones after about 5–10 passages are
shown. Note the small but distinct CD24-/CD44+ (M) populations appearing in all E clones
(circled), and the absence of CD24+/CD44- (E) cells in M clones. (B) Comparative expression
of E, M, and EM gene sets (S2 Table) relative to basal B or luminal cancer cell lines with expres-
sion as assessed by the GOBO online tool (http://co.bmc.lu.se/gobo/) [39]. This classifies E
genes as rather luminal-specific and M genes as more basal B-specific genes, and the EM gene
set as neutral. The same relative association with E and luminal and M genes and basal cell
lines, respectively, was found for the E_HMLER(150) and M_HMLER(150) signatures, as well
as for E and M specific gene sets (data not shown) from Taube et al (S2 Table).
(PDF)
S2 Fig. (Related to Fig 1): Dynamic expression of E and M genes in HMLER cell popula-
tions. (A,B) Heat maps of gene expression microarray data from adherent cells (adh) and sus-
pended mammospheres (ms) shown after relative normalization towards the intermediate
expression in E and M clones. (A) Expression of all transcripts that were enriched>5-fold in
suspension grown mammospheres versus the respective adherent cultures. The data show that
M genes (expressed higher in adherent M clones) are highly increased in HP mammospheres
while E genes (higher expressed in adherent E clones) are increased in M4 mammospheres.
Genes that are only enriched in HP mammospheres or only in M4 mammospheres were desig-
nated “context-dependent” and the intersection of genes enriched in both cell types as “con-
text-independent transcripts”. (B) Expression of genes expected to be expressed and previously
associated with high or low expression in HMEC-derived mammospheres [11]. (C) Pearson
correlation for E_HMLER (150) and M_HMLER (150) gene expression in whole population
microarrays of HP and M4 cells in adhesion and suspension. (D) Pearson correlation of single
cell transcriptomes (Biomark, Fluidigm) measured for 12 cells per group (groups as in C, every
column and line per individual cell) and 46 different genes (including, housekeeping genes, E
and M-specific genes, pluripotency factor encoding genes, suspension-specific genes) as indi-
cated in S4 Table. Data are from same experiment as shown in Fig 3D. Note the similarity of
gene expression correlation in whole population arrays (C) and single cell qPCR analysis: in ad-
hesion we observe a positive correlation between E cells, or between M cells, and anti-correla-
tion between E and M cells, while mammosphere derived cells individual E and M cells cannot
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be discriminated anymore by correlation.
(PDF)
S3 Fig. (Related to Fig 2): EM signatures predict poor outcome in ER+ and ER- breast can-
cer subtypes. Kaplan-Meier analysis for 6 different EM gene sets (24 genes) from HMLER and
HMLE cell lines (S2 Table) in luminal B (epithelial) and basal (mesenchymal) breast cancer pa-
tients (Kaplan-Meier-Plotter data set 2010, 72 basal patients, 208 luminal B patients). Numbers
of signatures with significant HRs indicating poor prognosis are indicated. Every triangle rep-
resents a different gene set. (A) Hazard ratio (HR) for overall survival is plotted against corre-
sponding logrank p-values. HR of>1 indicates poor outcome, HR<1 indicates good outcome.
(B) Hazard ratio for relapse-free survival is plotted against corresponding logrank p-values. (C)
Hazard ratios for overall survival is plotted against corresponding permuted p-values. Permut-
ed p-values were determined from a permutation test of 106 samples for the respective signa-
ture by calculating the probability of achieving a more extreme result with a random gene set
of the same size for overall survival of patients. (D) Kaplan–Meier analyses for overall patient
survival with gene sets derived by bootstrapping from all 22,772 analyzed probes. 10,000 differ-
ent gene sets consisting of 10 randomly picked genes were analyzed (every dot represents a dif-
ferent gene set). (E) Kaplan–Meier analyses for overall patient survival with gene sets derived
by bootstrapping from the most extreme 24 EM_HMLER genes. 10,000 different gene sets con-
sisting of 10 randomly picked genes were analyzed.
(PDF)
S4 Fig. (Related to Fig 3): CD24+/CD44- (E) cells can proliferate under suspension mam-
mospheres conditions and are not generated by CD24-/CD44+ (M) cells. (A) 500 CSFE-pos-
itive (CSFE+) cells expressing CD24+ /CD44- (E_CSFE) cells or CD24-/CD44+M cells
(M_CSFE) or 500 CSFE-negative (CSFE-, unlabeled) E andM cells (E_u, M_u) were sorted
fromHP cells as the indicated biological replicates and cultured in suspension mammosphere
conditions for 2 weeks, harvested, and analyzed for their retained CSFE label by quantitative
flow cytometry analyses. Bar graphs of relative numbers of CSFE- (proliferating, number indi-
cates CSFE- cell numbers) and CSFE+ (label retaining non-proliferating) cells from dissociated
mammospheres per well are shown. Note that the majority of replicates from both E and M cells
lost their CSFE label, indicative of proliferation and survival, even though CSFE labeling also ap-
peared toxic to E cells resulting in reduced cell numbers relative to unstained cells from the same
source (compare E_CSFE and E_u). (B) Representative CD24/CD44 flow cytometry profiles of
dissociated mammospheres (grown 2–3 weeks) from HMLER clones. Note that only cell lines
that originally contained E cells (E5 and HP cells) still contained distinct CD24+/CD44- popula-
tions but M1 and M4 cells had only a spotty appearance of less than 1% CD24+/CD44- cells,
supporting the plasticity of E cells and non-plasticity of M cells.
(PDF)
S5 Fig. (Related to Fig 3): Expression of selected E and M genes in HMLER cell lines and
HP subpopulations. (A) Heat map of selected E and M genes in microarrays of adherent
HMLER-derived cell lines (HP cells, 3 different E clones, 3 different M clones with different
passage numbers). The same microarray data as used for Fig 1A are shown as relative expres-
sion. (B) Heat map of relative gene expression of selected E and M genes assessed by qPCR
analysis of 100 AnnexinV-/PI- (live) sorted cells of the indicated sources grown in adhesion
(biological triplicates). Using these data we picked E and M genes for single cell qPCR analysis
shown in Fig 3D–3F. Note that the usually with the M phenotype associated genes SNAI1, FN,
CDH2, and CD44 are not consistently differentially expressed between adherent morphological
E and M cell types in arrays and/or qPCR analysis and thus were not used as M-specific genes.
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(C) Heat map of gene expression in single cells (before subtraction of background) from cell
populations grown under adherent or mammosphere suspension conditions as determined by
single cell qPCR analysis (same experiment as shown in Fig 3). No-template-controls (empty
wells) are designated NTC. Not detected data points are shown in gray. Biclustering based on
correlation analysis (using the heatmap.2 R function) of raw expression values including back-
ground of adherent and suspended E and M cells for the indicated genes clustered E and M
genes into two separate large clusters (the ones used in qPCR analysis are circled in orange and
blue), confirming their association with the opposite E and M cell-states. (D) Normalized aver-
age expression of individual genes in 24 adherent E cells (HP and E5 clone) versus in 24 adher-
ent M cells (M4 and M5 clones). ‘Not qualifying M genes’ did neither show a biological
significant effect-size in arrays, 100 cell- or single cell qPCR analyses. Asterisks mark genes sta-
tistically not significant to discriminate between E versusM state. Remarkably, possibly due to
the spotty expression of both E and M genes at the single cell level (gray: not detected or high
background as for CDH1, see C) a statistically significant difference of expression often did not
coincide with a large effect-size between E and M cell types (e.g. CDH1, TP63, ZEB2 or SNAI1),
while vice versa a small effect size could correlate with a high statistically significant difference
(CDH2, FN1, IL1R1, VIM).
(PDF)
S6 Fig. (Related to Fig 5): CD24+/CD44+ cells can spontaneously arise from E and M
clones. (A) Flow cytometry profile for cell surface CD24 and CD44 expression in HMLER
clones E5 and M4 grown in adhesion. Quadrant gate coordinates were determined using simul-
taneously measured HP cells. (B) Single cell qPCR analysis for two independently passaged
HP_late subpopulations (HP_late 1 and HP_late 2). Cells were stained for CD24 and CD44
and 20 cells per indicated cell line and gate were sorted. (C) PC1 and PC2 values of the individ-
ual cells (from Fig 5B and 5C) plotted against the variance of expression values per cell (expres-
sion value normalized to the maximum expression per gene in whole experiment). Cell
subpopulations are labelled according to their CD24/CD44 marker expression during sorting
(B). PC1 can be regarded as discriminating between the variance relative to the maximum (di-
versity), while PC2 was discriminating between E and M cell-types.
(PDF)
S1 Table. (Related to Fig 1): E_HMLER (150) and M_HMLER (150) signatures. The 150
most differentially expressed HMLER genes associated with respective E or M morphology
were derived from relative expression of grouped stable morphological E versus morphological
M clones, respective fold expression between grouped E and M clones is shown in brackets
(Limma, adjusted p-value< 0.01).
(XLSX)
S2 Table. (Related to Fig 2): Signatures used for Kaplan-Meier analyses. EM gene sets were
derived from HMLER (S1 Table) or from published gene sets derived from parental epithelial
versus mesenchymal HMLE cells [22] or lung cancer mesenchymal versus lung cancer epitheli-
al cell lines [38]. For HMLE gene sets mesenchymal HMLE cells had been generated by trans-
duction with vectors encoding siCDH1, TWIST, GSC, SNAI1 or by treatment with TGFβ and
E_HMLE genes were originally named EMT-DOWNREGULATED and M_HMLE genes were
originally designated as EMT_UPREGULATED. For the lung E and M gene sets genes had
been derived from microarrays from 93 lung cancer cell lines by comparing groups of cells
with high VIM and low CDH1 (mesenchymal genes) and low VIM and high CDH1 (epithelial
genes). Our EM gene sets were composed from the respective 30 or 12 most extremely express-
ed E genes and 30 or 12 M genes, to derive the EM signatures of 60 genes or 24 genes. The
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PCNA-metagene was derived by correlation expression analysis with expression of PCNA
from>1200 breast cancer microarrays using the GOBO online tool (http://co.bmc.lu.se/gobo/)
[39], while mammaprint [38] and NOS-TFs (targets of NANOG, OCT4 and SOX2 that are
transcription factors themselves)[46] were derived from the literature.
(XLSX)
S3 Table. (Related to Fig 1): Gene set enrichment analysis for mammospheres. GSEA using
the indicated E and M gene sets was performed using standard GSEA analysis. Inverse regula-
tion of E genes versus M genes from adhesion to suspension mammosphere cultures was ob-
served, independent whether gene sets were derived from HMLE or HMLER cell lines.
(PDF)
S4 Table. (Related to Figs 3D–3F and 5B): Taqman primer list. List of the Taqman assays
used for single cell and 100 cell qPCR analyses shown in Figs 3 and 5 are indicated and their
order numbers (Life Technologies) are shown.
(XLSX)
S5 Table. (Related to Figs 3D–3F and 5B): Statistical analysis for single cell qPCR data.
Normalized expression of the average expression of 10 E genes (CDH1, CD24, EPCAM, IL1B,
KRT5, LCN2, TP63, TRAIL, SLPI, S100A8) and 7 M genes (ABCA6, DCN, IL1R1, PCOLCE,
WNT5A, VIM, ZEB2) per cell was determined as plotted in the EM state space shown in Fig 3E
and 3F for the indicated different cell populations all grown in different wells under either ad-
hesion or suspension mammosphere conditions. To examine whether the difference as dis-
played in the EM state space was statistically significant between the different populations we
used the cross-match test (for E and M gene expression) and Mann-Whitney U test for E gene
expression or M gene expression. For the single cell data as displayed in Fig 5B, expression data
from three different CD24/CD44 cell populations of single cells from adherent HP_late1 and
HP_late 2 (plotted in the EM state space shown in Fig 5B) were tested for their differences
using the cross-match test and Mann-Whitney U test.
(PDF)
S6 Table. (Related to Fig 3D–3F): Raw single cell data. Raw measured Ct (Cq) values (48:48
chips, BioMark, Fluidigm) of single (1) and 100 cell qPCR data from HMLER-derived cell lines
either cultured in adhesion (adh), under mammosphere suspension conditions for two days
(2d) or for three weeks (3w). Primers for indicated genes were used as indicated in S4 Table.
Empty fields represent no amplification or data with insufficient quality. No template control
(NTC).
(XLSX)
S7 Table. (Related to Fig 5B): Raw single cell data. Raw measured Ct values of single (1) and
100 cell qPCR data from HMLER-derived cell lines and different CD24/CD44 subpopulations
cultured in adhesion conditions. Otherwise as for S6 Table.
(XLSX)
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